ACIP's Radical Shift on Hepatitis B Vaccination: A Threat to Public Health
The Advisory Committee on Immunization Practices (ACIP), a crucial body in shaping US vaccination policies, has taken a drastic turn, gutting the long-standing recommendation for universal hepatitis B vaccination at birth. The move is expected to be carried out by Robert F. Kennedy Jr., the current Secretary of Health and Human Services.
The committee voted 8-3 to overhaul its recommendation on the vaccine's dosing schedule, embracing an individual-based approach that allows parents to decide when their child should receive the first shot. Critics have lambasted this decision as a step into uncharted territory, citing the lack of credible data to justify it.
"This review found no benefit related to vaccine safety or protection of a delayed first dose compared with vaccination at birth, but identified critical risks of changing current U.S. recommendations," said a report from the Vaccine Integrity Project, which opposed this move prior to its announcement.
The ACIP's new approach has significant implications for public health, particularly in preventing hepatitis B infections in newborns. According to experts, 90% of childhood infections will become chronic, and about a quarter may lead to life-threatening conditions like cirrhosis and liver cancer.
"This review found no benefit related to vaccine safety or protection of a delayed first dose compared with vaccination at birth, but identified critical risks of changing current U.S. recommendations," said a report from the Vaccine Integrity Project
The ACIP's decision also has the potential to increase the risk of infections among vulnerable populations, including children born to mothers who are hepatitis B-positive.
Many groups and experts have voiced their opposition to this radical shift in vaccination policy, emphasizing that there is no scientific basis for altering the long-standing dosing schedule recommended by the Centers for Disease Control and Prevention (CDC).
"This review found no benefit related to vaccine safety or protection of a delayed first dose compared with vaccination at birth, but identified critical risks of changing current U.S. recommendations," said a report from the Vaccine Integrity Project.
The ACIP's new approach is seen as part of a larger trend in which Robert F. Kennedy Jr. and his allies are attempting to dismantle long-standing vaccine policies.
Critics have warned that this decision could lead to increased infections, increased healthcare costs, and untold harm to vulnerable populations, including children born with hepatitis B.
The decision has sparked outrage among many medical professionals and public health organizations, which still endorse the traditional dosing schedule for hepatitis B vaccination.
The Advisory Committee on Immunization Practices (ACIP), a crucial body in shaping US vaccination policies, has taken a drastic turn, gutting the long-standing recommendation for universal hepatitis B vaccination at birth. The move is expected to be carried out by Robert F. Kennedy Jr., the current Secretary of Health and Human Services.
The committee voted 8-3 to overhaul its recommendation on the vaccine's dosing schedule, embracing an individual-based approach that allows parents to decide when their child should receive the first shot. Critics have lambasted this decision as a step into uncharted territory, citing the lack of credible data to justify it.
"This review found no benefit related to vaccine safety or protection of a delayed first dose compared with vaccination at birth, but identified critical risks of changing current U.S. recommendations," said a report from the Vaccine Integrity Project, which opposed this move prior to its announcement.
The ACIP's new approach has significant implications for public health, particularly in preventing hepatitis B infections in newborns. According to experts, 90% of childhood infections will become chronic, and about a quarter may lead to life-threatening conditions like cirrhosis and liver cancer.
"This review found no benefit related to vaccine safety or protection of a delayed first dose compared with vaccination at birth, but identified critical risks of changing current U.S. recommendations," said a report from the Vaccine Integrity Project
The ACIP's decision also has the potential to increase the risk of infections among vulnerable populations, including children born to mothers who are hepatitis B-positive.
Many groups and experts have voiced their opposition to this radical shift in vaccination policy, emphasizing that there is no scientific basis for altering the long-standing dosing schedule recommended by the Centers for Disease Control and Prevention (CDC).
"This review found no benefit related to vaccine safety or protection of a delayed first dose compared with vaccination at birth, but identified critical risks of changing current U.S. recommendations," said a report from the Vaccine Integrity Project.
The ACIP's new approach is seen as part of a larger trend in which Robert F. Kennedy Jr. and his allies are attempting to dismantle long-standing vaccine policies.
Critics have warned that this decision could lead to increased infections, increased healthcare costs, and untold harm to vulnerable populations, including children born with hepatitis B.
The decision has sparked outrage among many medical professionals and public health organizations, which still endorse the traditional dosing schedule for hepatitis B vaccination.